Study AZ3110865, a Study Comparing SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-Moderate Alzheimer's Disease.
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2018
At a glance
- Drugs Intepirdine (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
- 07 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History